60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) has a beta value of 4.32 and has seen 13.08 million shares traded in the last trading session. The company, currently valued at $2.93M, closed the last trade at $1.27 per share which meant it lost -$0.13 on the day or -8.99% during that session. The SXTP stock price is -967.72% off its 52-week high price of $13.56 and 44.88% above the 52-week low of $0.70. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.26 million shares traded. The 3-month trading volume is 321.73K shares.
The consensus among analysts is that 60 Degrees Pharmaceuticals Inc (SXTP) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.65.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) trade information
Sporting -8.99% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the SXTP stock price touched $1.27 or saw a rise of 20.13%. Year-to-date, 60 Degrees Pharmaceuticals Inc shares have moved -1.22%, while the 5-day performance has seen it change -1.22%. Over the past 30 days, the shares of 60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP) have changed 10.80%. Short interest in the company has seen 37296.0 shares shorted with days to cover at 0.34.
60 Degrees Pharmaceuticals Inc (SXTP) estimates and forecasts
Figures show that 60 Degrees Pharmaceuticals Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -53.24% over the past 6 months, with this year growth rate of 79.42%, compared to 16.70% for the industry. Revenue growth from the last financial year stood is estimated to be 145.49%.
2 analysts offering their estimates for the company have set an average revenue estimate of 234k for the current quarter. 1 have an estimated revenue figure of 300k for the next ending quarter. Year-ago sales stood 125.68k and 116.46k respectively for this quarter and the next, and analysts expect sales will grow by 86.19% for the current quarter and 145.49% for the next.
SXTP Dividends
60 Degrees Pharmaceuticals Inc is expected to release its next earnings report in February this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
60 Degrees Pharmaceuticals Inc (NASDAQ:SXTP)’s Major holders
Insiders own 10.58% of the company shares, while shares held by institutions stand at 1.25% with a share float percentage of 1.40%. Investors are also buoyed by the number of investors in a company, with 60 Degrees Pharmaceuticals Inc having a total of 7.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund . As of Oct 31, 2024 , the former fund manager holds about 0.17% shares in the company for having 3.88 shares of worth $5056.0 while later fund manager owns 2.14 shares of worth $2788.0 as of Oct 31, 2024 , which makes it owner of about 0.09% of company’s outstanding stock.
